Take­da will trans­fer 300 staffers to CRO in on­go­ing R&D over­haul

Take­da is con­tin­u­ing a ma­jor over­haul of its R&D or­ga­ni­za­tion, trans­fer­ring 300 staffers to PRA, a glob­al clin­i­cal re­search or­ga­ni­za­tion which will now take the lead on the phar­ma com­pa­ny’s de­vel­op­ment ef­forts.

In a deal that PRA Chief Ex­ec­u­tive Of­fi­cer Col­in Shan­non called “the first of its kind in the CRO in­dus­try,” Take­da says that 300 em­ploy­ees in the U.S. and Eu­rope will get a chance to take new jobs at the CRO. And PRA will now be re­spon­si­ble for a full pipeline of re­search pro­grams, run­ning from Phase I through Phase IV post-mar­ket­ing stud­ies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER